Placulumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | TNF |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number |
|
ChemSpider |
|
UNII |
|
KEGG |
|
Chemical and physical data | |
Formula | C3404H5262N902O1036S22 |
Molar mass | 76104.14 g·mol−1 |
Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]
This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.
References
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Placulumab, American Medical Association.